Dow Up1.33% Nasdaq Up1.33%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
2.06 Down 0.10(4.63%) Jun 30, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.5
Mean Recommendation (last week):1.5
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:11.17
Median Target:11.00
High Target:17.00
Low Target:6.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Sep 22, 2015H.C. WainwrightInitiated Buy
Apr 28, 2015Brean CapitalInitiated Buy
Oct 21, 2014MLV & CoInitiated Buy
Aug 19, 2013StifelInitiated Buy
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333
Buy3444
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.